EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRU and the CUSIP is G3141W114. A total of 20 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $4,115,191 | +3.7% | 397,603 | 0.0% | 0.06% | -8.1% |
Q4 2022 | $3,968,078 | -0.5% | 397,603 | -50.0% | 0.06% | +37.8% |
Q3 2022 | $3,987,984 | +0.8% | 795,206 | +100.0% | 0.04% | -42.3% |
Q2 2022 | $3,956,000 | +0.7% | 397,603 | 0.0% | 0.08% | +66.0% |
Q1 2022 | $3,928,000 | -1.0% | 397,603 | 0.0% | 0.05% | +62.1% |
Q4 2021 | $3,968,000 | -0.2% | 397,603 | 0.0% | 0.03% | -14.7% |
Q3 2021 | $3,976,000 | -1.9% | 397,603 | -0.0% | 0.03% | -8.1% |
Q2 2021 | $4,052,000 | -0.1% | 397,692 | 0.0% | 0.04% | -19.6% |
Q1 2021 | $4,056,000 | – | 397,692 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|